Recall Of Magellan Lead Tests Just Keeps Getting Bigger And Bigger
Executive Summary
It’s the third expansion for a high-risk class I recall of LeadCare II, LeadCare Plus and LeadCare Ultra Blood Lead Tests.
You may also be interested in...
Three Facing Fraud Charges In Magellan Lead Test Debacle
The now-Meridian subsidiary’s former CEO, COO and regulatory affairs director reportedly delayed telling the FDA and the public about incorrect results obtained from Magellan’s LeadCare line of blood tests.
Magellan Lead Test Recall Expanded After First Attempted Fix Found Insufficient
Several additional batches of Magellan’s LeadCare II tests are being recalled as efforts to address the root cause continue.
Falsely Low Results Lead FDA To Affix Class I Designation To Recall Of Magellan Lead Tests
The LeadCare II, LeadCare Plus and LeadCare Ultra Blood Lead Tests made by Magellan Diagnostics Inc. were recalled because falsely low results could cause health risks to children and pregnant people.